Follow the BIOMERICA INC stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €4.6m. The latest transaction was reported on 27 August 2026 (Acquisition). Among the most active insiders: Irani Zackary S.. The full history is openly available.
28
Insider Decl.
n/a
Thresholds
€171,108
16 ops.
Buy Volume
n/a
n/a
Sell Volume
53Σ signal
Buys €171,108n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,869 of 28,932 companies
3.4
score / 100
Value
3
Quality
4
FCF yld-60%
Earn yld-77%
EV/EBITDA·
ROE-94%
Gross mgn9.4%
Net mgn-94%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,538 shares@ US$2.9411.3% of flowCommon StockSEC:0001513162-23-000011:0
Canonical exit: 27 Apr 2023 (T+90)
25 of 28 declarations
About BIOMERICA INC
BIOMERICA INC is a company focused on the development and manufacturing of diagnostic tests for human health. It primarily operates in the United States market.